Tezcan Gecgil

Tezcan Gecgil

Expertise: ETFs, Options Trading, Technical and Fundamental Analysis

Education: PhD (Business Studies), MSc (Investment Banking & Trading), MBA

Awards & Accomplishments: Completed all 3 levels of the Chartered Market Technician (CMT) qualification

About Tezcan
Tezcan Gecgil, PhD, began contributing to InvestorPlace in 2018. She has worked in investment management in the U.S. and U.K., including a Greenwich, Connecticut-based hedge fund as well as the American Stock Exchange, CFA Institute, and Bloomberg. She has also taught at various U.S. and U.K. universities.

She holds Ph.D. (Business Studies) as well as MSc (Investment Banking & Trading) and MBA degrees from leading U.S. and U.K. universities and has also completed all three levels of the Chartered Market Technician (CMT) examination.

Her passion is for options trading based on technical analysis of fundamentally strong companies. She especially enjoys setting up weekly covered calls for income generation. Publicly, she has also contributed to investing.com and the U.K. website of The Motley Fool. She is also part of the investment management writing team at Copylab.

When not navigating the markets, Tezcan delves into the mysteries of history and explores new destinations.

Recent Articles

3 Natural Gas Stocks Worth Your Time Today

Analysts are heavily debating the outlook for natural gas stocks in 2020. These three stocks offer value for long-term investors

WiMi Hologram Cloud Stock May Offer A Better Buying Opportunity In August

WiMi Hologram Cloud stock is volatile. Investors should exercise caution

In August, SAVE Stock May See $15 Before $20

The COVID-19 pandemic is still negatively affecting airlines. Therefore, SAVE stock will likely face further headwinds in August

Consider Taking Profits Now From Workhouse Group Stock

Workhouse Group is not yet profitable. Therefore, WKHS stock may come under pressure in the coming weeks as short-term profit-taking may hit the shares

As Optimism Wanes, the Ride May Be Over for Novavax stock

Novavax has been one of the companies cashing in on the race to find a vaccine against COVID-19. As a result NVAX stock is up over 3,000% year-to-date

Until Management Offers a Clear Path to Profitability, Avoid FCEL Stock

Despite FuelCell stock's recent success, lack of revenue creates a great deal of uncertainty for FCEL stock

5 Election Stocks to Buy as the Race Heats Up

The 2020 presidential election will be a heated race. Here are five election stocks to buy, regardless of who wins the White House

The 7 Best Dividend Stocks for Adventurous Investors

In 2002, many investors are in searching for the best dividend-paying stocks. Here are out top seven picks

Why Advanced Micro Devices Stock Belongs in Long-Term Portfolios

Advanced Micro Devices has strong focus on product innovation, which should drive AMD stock much higher in future quarters

Sorrento Therapeutics May Be Ready For a Pullback

Extreme volatility is name of the game with shares of small biotech companies such as Sorrento Therapeutics. Investors should be ready to embrace further choppiness in the coming weeks.